4.3 Article

Epigenetics of Aging

Journal

CURRENT GENOMICS
Volume 16, Issue 6, Pages 435-440

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389202916666150817203459

Keywords

Aging; Age-related diseases; DNA methylation; Epigenetics; External factors; Histone modifications; Non-coding RNAs

Funding

  1. Plan Nacional de I+D+I [2008-2011/2013-2016/FEDER, PI12/01080, PI11/01728]
  2. Fundacion Ramon Areces
  3. ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion [CP11/00131]
  4. Obra Social Cajastur, Spain

Ask authors/readers for more resources

The best-known phenomenon exemplifying epigenetic drift (the alteration of epigenetic patterns during aging) is the gradual decrease of global DNA methylation. Aging cells, different tissue types, as well as a variety of human diseases possess their own distinct DNA methylation profiles, although the functional impact of these is not always clear. DNA methylation appears to be a dynamic tool of transcriptional regulation, with an extra layer of complexity due to the recent discovery of the conversion of 5-methylcytosine into 5-hydroxymethylcytosine. This age-related DNA demethylation is associated with changes in histone modification patterns and, furthermore, we now know that ncRNAs have evolved in eukaryotes as epigenetic regulators of gene expression. In this review, we will discuss current knowledge on how all these epigenetic phenomena are implicated in human aging, and their links with external, internal and stochastic factors which can affect human age-related diseases onset.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming

Dafni Chondronasiou, Diljeet Gill, Lluc Mosteiro, Rocio G. Urdinguio, Antonio Berenguer, Monica Aguilera, Sylvere Durand, Fanny Aprahamian, Nitharsshini Nirmalathasan, Maria Abad, Daniel E. Martin-Herranz, Camille Stephan Otto-Attolini, Neus Prats, Guido Kroemer, Mario F. Fraga, Wolf Reik, Manuel Serrano

Summary: A single period of OSKM expression can induce epigenetic, transcriptomic, and metabolomic changes towards a younger configuration in multiple tissues.

AGING CELL (2022)

Article Chemistry, Analytical

Enhanced Detection of Viral RNA Species Using Fokl-Assisted Digestion of DNA Duplexes and DNA/RNA Hybrids

Juan R. Tejedor, Gabriel Martin, Annalisa Roberti, Cristina Mangas, Pablo Santamarina-Ojeda, Raul Fernandez Perez, Virginia Lopez, Rocio Gonzalez Urdinguio, Juan J. Alba-Linares, Alfonso Penarroya, Marta E. Alvarez-Arguelles, Jose A. Boga, Agustin Fernandez Fernandez, Susana Rojo-Alba, Mario Fernandez Fraga

Summary: This study presents a novel method to amplify detection of RNA molecules in complex samples, improving the sensitivity and specificity of detecting specific pathogens. The new method enhances signal by digesting DNA/RNA hybrids, reducing the limit of detection compared to traditional methods, and exhibits high specificity to target molecules.

ANALYTICAL CHEMISTRY (2022)

Article Hematology

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms

Antonio Lahera, Pilar Lopez-Nieva, Hernan Alarcon, Jose L. Marin-Rubio, Maria A. Cobos-Fernandez, Pablo Fernandez-Navarro, Agustin F. Fernandez, Laura Vela-Martin, Isabel Sastre, Sara Ruiz-Garcia, Pilar Llamas, Jose L. Lopez-Lorenzo, Javier Cornago, Javier Santos, Jose Fernandez-Piqueras, Maria Villa-Morales

Summary: Despite frequent alterations in the JAK/STAT pathway in T-ALL/LBL, there is currently no approved therapy for patients with constitutive JAK/STAT signaling. This study identifies SOCS3 hypermethylation as a recurrent event in T-ALL/LBL and demonstrates its potential as a therapeutic target by counteracting the constitutive activation of the JAK/STAT pathway through different molecular mechanisms.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways

Juan Jose Alba-Linares, Raul F. Perez, Juan Ramon Tejedor, David Bastante-Rodriguez, Francisco Ponce, Nuria Garcia Carbonell, Rafael Gomez Zafra, Agustin F. Fernandez, Mario F. Fraga, Empar Lurbe

Summary: Maternal obesity or gestational diabetes mellitus are significant risk factors for cardiometabolic diseases in children. A study on the DNA methylation landscape of children born to mothers with obesity and gestational diabetes found abundant methylation changes during the first 6 months of life, associated with genes and pathways involved in fatty acid metabolism, developmental processes, and mitochondrial bioenergetics. The study also revealed an interaction between developmental methylation changes and maternal metabolic alterations.

CARDIOVASCULAR DIABETOLOGY (2023)

Article Gastroenterology & Hepatology

The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

Naroa Goikoetxea-Usandizaga, Miren Bravo, Leire Egia-Mendikute, Leticia Abecia, Marina Serrano-Macia, Rocio G. Urdinguio, Marc Clos-Garcia, Ruben Rodriguez-Agudo, Raquel Araujo-Legido, Lucia Lopez-Bermudo, Teresa C. Delgado, Sofia Lachiondo-Ortega, Irene Gonzalez-Recio, Claudia Gil-Pitarch, Ainize Pena-Cearra, Jorge Simon, Raquel Benede-Ubieto, Silvia Arino, Jose M. Herranz, Mikel Azkargorta, Julio Salazar-Bermeo, Nuria Marti, Marta Varela-Rey, Juan M. Falcon-Perez, Oscar Lorenzo, Ruben Nogueiras, Felix Elortza, Yulia A. Nevzorova, Francisco J. Cubero, Domingo Saura, Luis Alfonso Martinez-Cruz, Guadalupe Sabio, Asis Palazon, Pau Sancho-Bru, Natalia Elguezabal, Mario F. Fraga, Matias A. Avila, Ramon Bataller, Jose J. G. Marin, Franz Martin, Maria Luz Martinez-Chantar

Summary: Alcohol-associated liver disease (ALD), accounting for 70% of liver-related deaths in Europe, has no effective approved therapies. However, targeting methylation-controlled J protein (MCJ) may help in recovering mitochondrial fitness without collateral oxidative damage. Liver-specific MCJ silencing can prevent major ALD hallmarks, such as mitochondrial dysfunction, steatosis, inflammation, and oxidative stress, improving lipid metabolism and liver injury.

HEPATOLOGY (2023)

Article Multidisciplinary Sciences

The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

Lucia Morgado-Palacin, Jessie A. Brown, Thomas F. Martinez, Juana M. Garcia-Pedrero, Farhad Forouhar, S. Aidan Quinn, Clara Reglero, Joan Vaughan, Yasamin Hajy Heydary, Cynthia Donaldson, Sandra Rodriguez-Perales, Eva Allonca, Rocio Granda-Diaz, Agustin F. Fernandez, Mario F. Fraga, Arianna L. Kim, Jorge Santos-Juanes, David M. Owens, Juan P. Rodrigo, Alan Saghatelian, Adolfo A. Ferrando

Summary: The TINCR gene plays an important role in epithelium tissues, controlling human epidermal differentiation and wound healing. It has been found to have tumor suppressor properties in squamous cell carcinoma (SCC), being upregulated by UV-induced DNA damage in a TP53-dependent manner. TINCR expression inhibits the growth of SCC cells in vitro and in vivo, and deletion or mutation of the TINCR gene has been observed in SCC clinical samples. These findings highlight the significance of TINCR as a protein coding tumor suppressor gene lost in squamous cell carcinomas.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Circulating miRNA expression in long-standing type 1 diabetes mellitus

Paula Morales-Sanchez, Carmen Lambert, Jessica Ares-Blanco, Lorena Suarez-Gutierrez, Elsa Villa-Fernandez, Ana Victoria Garcia, Miguel Garcia-Villarino, Juan Ramon Tejedor, Mario F. Fraga, Edelmiro Menendez Torre, Pedro Pujante, Elias Delgado

Summary: This study aimed to analyze the circulating miRNA expression profile of patients with type 1 diabetes and no other associated pathology. The expression of hsa-miR-1-3p was found to be significantly increased in patients with type 1 diabetes and positively correlated with glycated haemoglobin levels. Changes in hsa-miR-1-3p were also found to directly affect genes involved in vascular development and cardiovascular pathologies. Circulating hsa-miR-1-3p, along with glycemic control, could be used as prognostic biomarkers in type 1 diabetes to prevent the development of vascular complications in these patients.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis

Annalisa Roberti, Juan Ramon Tejedor, Irene Diaz-Moreno, Virginia Lopez, Pablo Santamarina-Ojeda, Raul F. Perez, Rocio G. Urdinguio, Carmen Concellon, Maria Luz Martinez-Chantar, Juan Luis Fernandez-Morera, Antonio Diaz-Quintana, Vicente del Amo, Agustin F. Fernandez, Mario F. Fraga

Summary: Obesity is associated with dysfunction of adipose tissue, and this study identifies the role of nicotinamide N-methyltransferase (NNMT) in the adipogenesis process. NNMT is transactivated by CCAAT/Enhancer Binding Protein beta (CEBPB) during the early phase of adipocyte differentiation. Knockout and inhibition of NNMT impair terminal adipogenesis, suggesting that NNMT is a key component during the early stages of adipogenesis and could be a potential therapeutic target for obesity.

SCIENTIFIC REPORTS (2023)

Article Oncology

Multi-omic integration of DNA methylation and gene expression data reveals molecular vulnerabilities in glioblastoma

Pablo Santamarina-Ojeda, Juan Ramon Tejedor, Raul F. Perez, Virginia Lopez, Annalisa Roberti, Cristina Mangas, Agustin F. Fernandez, Mario F. F. Fraga

Summary: Glioblastoma (GBM) is an aggressive and heterogeneous type of cancer, posing challenges in developing effective treatments. Incorporating molecular features into diagnosis has improved categorization of GBM subtypes, revealing subtype-specific vulnerabilities. By integrating gene expression and DNA methylation data, potential vulnerabilities in GBM patients were identified, implicating the AP-1, SMAD3, and RUNX1/RUNX2 pathways in tumor development. Inhibition of these pathways, with or without the chemotherapy agent temozolomide, led to impaired tumor growth, particularly in the aggressive, mesenchymal-like subtype. These findings have implications for personalized therapeutic approaches.

MOLECULAR ONCOLOGY (2023)

Article Cell Biology

DPPA3-HIF1a axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype

Estefania Cuesta-Borras, Candida Salvans, Oriol Arques, Irene Chicote, Lorena Ramirez, Laia Cabellos, Jordi Martinez-Quintanilla, Alex Mur-Espinosa, Alejandro Garcia-Alvarez, Jorge Hernando, Juan Ramon Tejedor, Oriol Mirallas, Elena Elez, Mario F. Fraga, Josep Tabernero, Paolo Nuciforo, Jaume Capdevila, Hector G. Palmer, Isabel Puig

Summary: Tumor relapse and chemoresistance are major challenges in cancer therapy. This study reveals that DPPA3 plays a crucial role in promoting slow-cycling and chemoresistant phenotype in colorectal cancer. The study also uncovers a feedback loop between DPPA3 and HIF1a that regulates cell-cycle progression and highlights the potential of downregulating HIF1a to restore chemosensitivity. Furthermore, DPPA3 overexpression is identified as a biomarker for chemotherapeutic resistance in CRC patients.

CELL REPORTS (2023)

Article Oncology

CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

Juan Ramon Tejedor, Alfonso Penarroya, Javier Gancedo-Verdejo, Pablo Santamarina-Ojeda, Raul F. Perez, Sara Lopez-Tamargo, Ana Diez-Borge, Juan J. Alba-Linares, Nerea Gonzalez-del-Rey, Rocio G. Urdinguio, Cristina Mangas, Annalisa Roberti, Virginia Lopez, Teresa Morales-Ruiz, Rafael R. Ariza, Teresa Roldan-Arjona, Monica Meijon, Luis Valledor, Maria Jesus Canal, Daniel Fernandez-Martinez, Maria Fernandez-Hevia, Paula Jimenez-Fonseca, Luis J. Garcia-Florez, Agustin F. Fernandez, Mario F. Fraga

Summary: This study utilized a multi-omics approach to identify gene candidates with strong correlations between DNA methylation and gene expression in human colorectal cancer (CRC) samples and colon cancer cell lines. The researchers used CRISPR-Cas9 epigenome editing tools to modulate the DNA methylation status of 56 promoters previously linked with epigenetic repression in CRC and assessed the functional consequences. Overall, the epigenetic modulation had a mild impact on gene expression reactivation and cancer cell viability, but the reactivation of RSPO2 was associated with impaired cell proliferation in p53(-/-) cancer cell lines.

CLINICAL EPIGENETICS (2023)

No Data Available